Disease	B:C1303150
management	I:C1303150
programs	I:C1303150
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
in	O
Germany	O
:	O
a	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
descriptive	I:C1709599
study	I:C1709599
.	O

Disease	O
management	I:C1303150
programs	I:C1303150
for	O
patients	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
in	O
Germany	O
:	O
a	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
descriptive	I:C1709599
study	I:C1709599
.	O

Disease	O
management	I:C1303150
programs	I:C1303150
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
in	O
Germany	B:C0017480
:	O
a	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
descriptive	I:C1709599
study	I:C1709599
.	O

Disease	O
management	I:C1303150
programs	I:C1303150
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
in	O
Germany	O
:	O
a	O
longitudinal	B:C0205127
population	O
-	I:C1709599
based	I:C1709599
descriptive	I:C1709599
study	I:C1709599
.	O

Disease	O
management	I:C1303150
programs	I:C1303150
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
in	O
Germany	O
:	O
a	O
longitudinal	O
population	B:C1709599
-	I:C1709599
based	I:C1709599
descriptive	I:C1709599
study	I:C1709599
.	O

The	O
primary	O
aim	O
of	O
the	O
disease	B:C1303150
management	I:C1303150
program	I:C1303150
(	O
disease	O
management	I:C1303150
program	I:C1303150
)	O
for	O
patients	O
with	O
diabetes	O
mellitus	I:C0011860
type	I:C0011860
2	I:C0011860
is	O
to	O
improve	O
the	O
quality	O
of	O
health	O
care	I:C0086388
and	O
the	O
treatment	O
process	O
.	O

The	O
primary	O
aim	O
of	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
(	O
disease	B:C1303150
management	I:C1303150
program	I:C1303150
)	O
for	O
patients	O
with	O
diabetes	O
mellitus	I:C0011860
type	I:C0011860
2	I:C0011860
is	O
to	O
improve	O
the	O
quality	O
of	O
health	O
care	I:C0086388
and	O
the	O
treatment	O
process	O
.	O

The	O
primary	O
aim	O
of	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
(	O
disease	O
management	I:C1303150
program	I:C1303150
)	O
for	O
patients	O
with	O
diabetes	B:C0011860
mellitus	I:C0011860
type	I:C0011860
2	I:C0011860
is	O
to	O
improve	O
the	O
quality	O
of	O
health	O
care	I:C0086388
and	O
the	O
treatment	O
process	O
.	O

The	O
primary	O
aim	O
of	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
(	O
disease	O
management	I:C1303150
program	I:C1303150
)	O
for	O
patients	O
with	O
diabetes	O
mellitus	I:C0011860
type	I:C0011860
2	I:C0011860
is	O
to	O
improve	B:C0184511
the	O
quality	O
of	O
health	O
care	I:C0086388
and	O
the	O
treatment	O
process	O
.	O

The	O
primary	O
aim	O
of	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
(	O
disease	O
management	I:C1303150
program	I:C1303150
)	O
for	O
patients	O
with	O
diabetes	O
mellitus	I:C0011860
type	I:C0011860
2	I:C0011860
is	O
to	O
improve	O
the	O
quality	O
of	O
health	B:C0086388
care	I:C0086388
and	O
the	O
treatment	O
process	O
.	O

12	O
years	O
after	O
its	O
introduction	O
in	O
Germany	B:C0017480
,	O
there	O
is	O
still	O
no	O
consensus	O
as	O
to	O
whether	O
disease	O
management	I:C1303150
program	I:C1303150
has	O
been	O
effective	O
in	O
reaching	O
these	O
goals	O
.	O

12	O
years	O
after	O
its	O
introduction	O
in	O
Germany	O
,	O
there	O
is	O
still	O
no	O
consensus	O
as	O
to	O
whether	O
disease	B:C1303150
management	I:C1303150
program	I:C1303150
has	O
been	O
effective	O
in	O
reaching	O
these	O
goals	O
.	O

A	O
retrospective	O
longitudinal	B:C0205127
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	B:C1709599
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	B:C0220825
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	B:C1303150
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	B:C0025102
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	B:C0027452
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	O
of	O
Bavaria	O
.	O

A	O
retrospective	O
longitudinal	O
population	O
-	I:C1709599
based	I:C1709599
study	I:C1709599
between	O
2004	O
and	O
2015	O
were	O
conducted	O
to	O
evaluate	O
the	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
in	O
Bavaria	O
using	O
routinely	O
collected	O
patient	O
medical	O
records	I:C0025102
hold	O
from	O
the	O
National	O
Association	I:C0027452
of	I:C0027452
Statutory	I:C0027452
Health	I:C0027452
Insurance	I:C0027452
Physicians	B:C0031831
of	O
Bavaria	O
.	O

During	O
the	O
first	O
12	O
years	O
of	O
disease	B:C1303150
management	I:C1303150
program	I:C1303150
,	O
the	O
number	O
of	O
participants	O
increased	O
continually	O
to	O
reach	O
580,222	O
in	O
2015	O
.	O

During	O
the	O
first	O
12	O
years	O
of	O
disease	O
management	I:C1303150
program	I:C1303150
,	O
the	O
number	O
of	O
participants	B:C0679646
increased	O
continually	O
to	O
reach	O
580,222	O
in	O
2015	O
.	O

The	O
proportion	O
of	O
participants	B:C0679646
older	O
than	O
70	O
years	O
increased	O
during	O
the	O
observation	O
from	O
41.6	O
to	O
51.1	O
%	O
.	O

The	O
percentage	O
of	O
smokers	B:C0337664
increased	O
slightly	O
from	O
9	O
to	O
11	O
%	O
.	O

Similarly	O
,	O
the	O
distribution	O
of	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
remained	O
with	O
approximately	O
50	O
%	O
of	O
patients	O
having	O
a	O
body	O
mass	I:C1305855
index	I:C1305855
>	O
30	O
kg	O
/	O
m	O
(	O
2	O
)	O
.	O

Similarly	O
,	O
the	O
distribution	O
of	O
body	O
mass	I:C1305855
index	I:C1305855
remained	O
with	O
approximately	O
50	O
%	O
of	O
patients	O
having	O
a	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
>	O
30	O
kg	O
/	O
m	O
(	O
2	O
)	O
.	O

Control	O
of	O
HbA1c	B:C0019018
was	O
without	O
an	O
appreciable	O
change	O
over	O
the	O
course	O
,	O
with	O
between	O
8.3	O
and	O
9.4	O
%	O
of	O
all	O
patients	O
with	O
uncontrolled	O
values	O
higher	O
than	O
8.5	O
%	O
.	O

Prescription	B:C0033080
of	O
metformin	O
increased	O
from	O
40.5	O
%	O
in	O
2004	O
to	O
54.1	O
%	O
in	O
2015	O
.	O

Prescription	O
of	O
metformin	B:C0025598
increased	O
from	O
40.5	O
%	O
in	O
2004	O
to	O
54.1	O
%	O
in	O
2015	O
.	O

Among	O
patients	O
receiving	O
insulin	B:C0021641
,	O
the	O
proportion	O
receiving	O
a	O
combined	O
therapy	I:C0009429
with	O
metformin	O
increased	O
from	O
28.4	O
%	O
in	O
2004	O
to	O
50.8	O
%	O
in	O
2015	O
.	O

Among	O
patients	O
receiving	O
insulin	O
,	O
the	O
proportion	O
receiving	O
a	O
combined	B:C0009429
therapy	I:C0009429
with	O
metformin	O
increased	O
from	O
28.4	O
%	O
in	O
2004	O
to	O
50.8	O
%	O
in	O
2015	O
.	O

Among	O
patients	O
receiving	O
insulin	O
,	O
the	O
proportion	O
receiving	O
a	O
combined	O
therapy	I:C0009429
with	O
metformin	B:C0025598
increased	O
from	O
28.4	O
%	O
in	O
2004	O
to	O
50.8	O
%	O
in	O
2015	O
.	O

In	O
contrast	O
,	O
the	O
percentage	O
with	O
insulin	B:C0021641
monotherapy	O
decreased	O
from	O
55.4	O
to	O
33.7	O
%	O
.	O

In	O
contrast	O
,	O
the	O
percentage	O
with	O
insulin	O
monotherapy	B:C0087111
decreased	O
from	O
55.4	O
to	O
33.7	O
%	O
.	O

The	O
proportion	O
of	O
patients	O
with	O
a	O
diabetic	B:C0204935
education	I:C0204935
increased	O
within	O
the	O
course	O
from	O
12.8	O
to	O
29.3	O
%	O
.	O

Data	O
from	O
the	O
German	B:C0017480
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
demonstrates	O
an	O
improvement	O
in	O
the	O
quality	O
of	I:C0034379
care	I:C0034379
with	O
respect	O
to	O
pharmacotherapy	O
and	O
patient	O
education	O
and	O
therefore	O
to	O
an	O
improved	O
adherence	O
to	O
guidelines	O
.	O

Data	O
from	O
the	O
German	O
disease	B:C1303150
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
demonstrates	O
an	O
improvement	O
in	O
the	O
quality	O
of	I:C0034379
care	I:C0034379
with	O
respect	O
to	O
pharmacotherapy	O
and	O
patient	O
education	O
and	O
therefore	O
to	O
an	O
improved	O
adherence	O
to	O
guidelines	O
.	O

Data	O
from	O
the	O
German	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
demonstrates	O
an	O
improvement	O
in	O
the	O
quality	O
of	I:C0034379
care	I:C0034379
with	O
respect	O
to	O
pharmacotherapy	O
and	O
patient	O
education	O
and	O
therefore	O
to	O
an	O
improved	O
adherence	O
to	O
guidelines	O
.	O

Data	O
from	O
the	O
German	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
demonstrates	O
an	O
improvement	O
in	O
the	O
quality	B:C0034379
of	I:C0034379
care	I:C0034379
with	O
respect	O
to	O
pharmacotherapy	O
and	O
patient	O
education	O
and	O
therefore	O
to	O
an	O
improved	O
adherence	O
to	O
guidelines	O
.	O

Data	O
from	O
the	O
German	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
demonstrates	O
an	O
improvement	O
in	O
the	O
quality	O
of	I:C0034379
care	I:C0034379
with	O
respect	O
to	O
pharmacotherapy	B:C0013216
and	O
patient	O
education	O
and	O
therefore	O
to	O
an	O
improved	O
adherence	O
to	O
guidelines	O
.	O

Data	O
from	O
the	O
German	O
disease	O
management	I:C1303150
program	I:C1303150
for	O
type	O
2	I:C0011860
diabetes	I:C0011860
demonstrates	O
an	O
improvement	O
in	O
the	O
quality	O
of	I:C0034379
care	I:C0034379
with	O
respect	O
to	O
pharmacotherapy	O
and	O
patient	O
education	O
and	O
therefore	O
to	O
an	O
improved	O
adherence	O
to	O
guidelines	B:C0162791
.	O

However	O
,	O
no	O
appreciable	O
improvement	O
was	O
observed	O
with	O
regard	O
to	O
smoking	B:C1519386
status	I:C1519386
,	O
obesity	O
or	O
HbA1c	O
control	O
.	O

However	O
,	O
no	O
appreciable	O
improvement	O
was	O
observed	O
with	O
regard	O
to	O
smoking	O
status	I:C1519386
,	O
obesity	B:C0028754
or	O
HbA1c	O
control	O
.	O

However	O
,	O
no	O
appreciable	O
improvement	O
was	O
observed	O
with	O
regard	O
to	O
smoking	O
status	I:C1519386
,	O
obesity	O
or	O
HbA1c	B:C0019018
control	O
.	O

